| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.33B | 42.65B | 41.37B | 41.23B | 51.03B | 38.96B |
| Gross Profit | 6.52B | 6.50B | 6.21B | 4.73B | 9.45B | 6.73B |
| EBITDA | 2.21B | 1.94B | 1.94B | 435.00M | 4.81B | 2.44B |
| Net Income | 556.00M | -1.23B | 350.00M | -630.00M | 2.17B | 1.02B |
Balance Sheet | ||||||
| Total Assets | 47.33B | 48.94B | 50.63B | 49.19B | 49.90B | 43.58B |
| Cash, Cash Equivalents and Short-Term Investments | 2.32B | 2.65B | 2.10B | 2.33B | 1.90B | 2.00B |
| Total Debt | 12.92B | 14.33B | 14.85B | 12.40B | 10.12B | 7.21B |
| Total Liabilities | 23.54B | 25.97B | 26.77B | 25.64B | 25.07B | 20.56B |
| Stockholders Equity | 23.74B | 22.92B | 23.82B | 23.50B | 24.78B | 22.97B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.62B | -1.74B | -690.00M | -2.10B | -862.00M |
| Operating Cash Flow | 0.00 | 5.27B | 152.00M | 1.52B | -1.21B | 341.00M |
| Investing Cash Flow | 0.00 | -3.85B | -2.48B | -2.21B | -1.24B | -529.00M |
| Financing Cash Flow | 0.00 | -876.00M | 2.11B | 1.12B | 2.35B | -624.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥43.46B | 9.64 | ― | 2.86% | 6.10% | 19.77% | |
78 Outperform | ¥29.10B | 9.99 | ― | 3.82% | 8.69% | 18.95% | |
69 Neutral | ¥16.33B | 11.91 | ― | 2.41% | 1.49% | 8.48% | |
65 Neutral | ¥94.45B | 21.35 | ― | 3.41% | 5.24% | -71.41% | |
65 Neutral | ¥82.42B | 11.45 | ― | 2.35% | 11.86% | 207.24% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥10.74B | -8.57 | ― | 2.30% | 3.10% | -450.60% |